- Research works
- 1 ▼ 9% vs 2013–17
- Citations
- 12 9.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 80% world 28%
Not ranked overall: For Robin (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does For Robin (United States) publish most on?
By volume in 2022–2025: Extracellular vesicles in disease, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses and Protease and Inhibitor Mechanisms.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Extracellular vesicles in disease Molecular Biology 0 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 3 Immunotherapy and Immune Responses Immunology 0 works
- 4 Protease and Inhibitor Mechanisms Cancer Research 0 works
- 5 Lung Cancer Research Studies Oncology 0 works
- 6 Glycosylation and Glycoproteins Research Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has For Robin (United States)'s research output changed?
Output in 2018–2022 was 9% lower than in 2013–2017.
Other research institutions in Williamsville
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.